home / stock / cgtx / cgtx news

CGTX News and Press, Cognition Therapeutics Inc. From 05/13/22

Stock Information
Company Name: Cognition Therapeutics Inc.
Stock Symbol: CGTX
Market: NASDAQ
Website: cogrx.com
Menu
CGTX CGTX Quote CGTX Short CGTX News CGTX Articles CGTX Message Board
Get CGTX Alerts

News, Short Squeeze, Breakout and More Instantly...
CGTX - Cognition Therapeutics to Participate in H.C. Wainwright Global Investment Conference

PURCHASE, N.Y., May 13, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage neuroscience company developing therapies that treat age-related degenerative diseases of the central nervous system and retina (the “Company” or “Cog...
CGTX - Cognition Therapeutics GAAP EPS of $0.17 beats by $0.46

Cognition Therapeutics press release (NASDAQ:CGTX): Q1 GAAP EPS of $0.17 beats by $0.46. Cash and cash equivalents of $51.51M For further details see: Cognition Therapeutics GAAP EPS of $0.17 beats by $0.46

CGTX - Cognition Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update

Treatment Commences in Second Cohort of Phase 2 SHINE Study in Mild-to-Moderate Alzheimer’s Disease Data Presented at Scientific Conferences Further Validate the Potential of σ-2 Modulators PURCHASE, N.Y., May 11, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeu...

CGTX - CORRECTION -- Cognition Therapeutics to Report First Quarter 2022 Financial Results on May 11, 2022

PURCHASE, N.Y., May 04, 2022 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Cognition Therapeutics, Inc. (NASDAQ: CGTX), please note that in the first paragraph of the release, the report date should be Wednesday, May 11, 2022, not Tuesday as previously sta...
CGTX - Cognition Therapeutics to Report First Quarter 2022 Financial Results on May 11, 2022

PURCHASE, N.Y., May 04, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage neuroscience company developing therapies that treat age-related degenerative diseases of the central nervous system and retina (the “Company” or “...

CGTX - Cognition Therapeutics Presented Preclinical Findings Showing that Sigma-2 Receptor Modulators Rescue Trafficking Deficits in Retinal Pigment Epithelial Cells in Model of Dry AMD

NEW YORK, May 03, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics , Inc. (NASDAQ: CGTX) , a clinical stage neuroscience company developing therapies that treat age-related degenerative diseases of the central nervous system and retina, presented a poster today at the ann...

CGTX - Cognition Therapeutics to Present Preclinical Results Demonstrating Therapeutic Potential for Sigma-2 Receptor Modulators in Dry Age-Related Macular Degeneration

NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics , Inc. (NASDAQ: CGTX) , a clinical stage neuroscience company developing drugs that treat age-related degenerative diseases of the central nervous system and retina, will be presenting a poster a...
CGTX - Cognition Therapeutics Announces Participation in B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference

PURCHASE, N.Y., April 25, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage neuroscience company developing drugs to treat age-related degenerative diseases of the central nervous system and retina, today announced that members of its management team...

CGTX - Cognition Therapeutics Announces Participation in 21st Annual Needham Virtual Healthcare Conference

PURCHASE, N.Y., April 06, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical stage neuroscience company developing drugs to treat age-related degenerative diseases of the central nervous system and retina, today announced that the company would be participa...

CGTX - VTNR, TKAT and ISIG among mid-day movers

Gainers: Protalix BioTherapeutics (PLX) +74%. Aterian (ATER) +62%. Dingdong Limited (DDL) +40%. Jumia Technologies (JMIA) +30%. Twitter (TWTR) +27%. Takung Art (TKAT) +24%. Gracell Biotechnologies (GRCL) +22%. Cognition Therapeutics (CGTX) +21%. Poema Global Holdings (PPGH) +20%. Biophytis (B...
Previous 10 Next 10